Finanzwire Finanzwire
Basculer en Français
10000 Companies
202918 Keywords
133504 Articles
107744 Press releases
Headlines Articles Press releases Kedrion Remove
  1. Home
  2. Companies
  3. Kedrion
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/27/2025 at 10:10, 3 months 12 days ago

    EMA Grants Orphan Drug Designation to Kedrion's Treatment for ACP

    Biopharmaceutical Innovation Kedrion Orphan Drug EMA Approval Iron Metabolism
  • PRESS RELEASE

    published on 11/27/2025 at 10:05, 3 months 12 days ago

    European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism

    Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation
    Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
    Logo of Kedrion
  • BRIEF

    published on 11/06/2025 at 14:50, 4 months 3 days ago

    Kedrion Highlights Secondary Immunodeficiencies at IPIC 2025

    Kedrion Biopharma Hematologic Malignancies Secondary Immunodeficiencies IPIC 2025 Immunoglobulin Therapy
  • PRESS RELEASE

    published on 11/06/2025 at 14:45, 4 months 3 days ago

    Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care

    Kedrion Biopharma shines spotlight on Secondary Immunodeficiencies at IPIC 2025, highlighting challenges and advances in patient care
    Innovation Patient Care Kedrion Biopharma Secondary Immunodeficiencies IPIC 2025
    Logo of Kedrion
Accesswire
  • Published on 03/09/2026 at 17:15, 2 hours 1 minute ago

    Alta Copper Corp. and Nascent Exploration Pty Ltd Announce Completion of Plan of Arrangement

  • Published on 03/09/2026 at 14:00, 5 hours 16 minutes ago

    urban-gro, Inc. Regains Full Nasdaq Compliance Following Balance Sheet and Governance Improvements

  • Published on 03/09/2026 at 14:00, 5 hours 16 minutes ago

    Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants

  • Published on 03/09/2026 at 13:00, 6 hours 16 minutes ago

    Avant Brands Continues to Strengthen Balance Sheet with $1.77 Million Debt Retirement at $0.935 Per Unit

  • Published on 03/09/2026 at 13:00, 6 hours 16 minutes ago

    Unusual Machines Fourth Quarter and Full Year 2025 Shareholder Letter

View all ACCESSWIRE
EQS Group
  • Published on 03/09/2026 at 19:05, 11 minutes ago

    Ridgewood Infrastructure Acquires Sierra Railroad Company

  • Published on 03/09/2026 at 18:41, 35 minutes ago

    POS-Transaction in Own Shares

  • Published on 03/09/2026 at 16:30, 2 hours 46 minutes ago

    Huawei Debuts "Driving Mobility and Logistics into the Intelligent World" Vision for Transportation, Powered by Five New Solutions

  • Published on 03/09/2026 at 15:57, 3 hours 19 minutes ago

    Commerzbank completes share buyback of €524m

  • Published on 03/09/2026 at 15:53, 3 hours 23 minutes ago

    Commerzbank completes share buyback of €524m

View all EQS
Les Echos
  • Published on 03/09/2026 at 18:43, 33 minutes ago

    Reporting on share buyback transactions carried out between March 2 and March 6, 2026

  • Published on 03/09/2026 at 18:00, 1 hour 16 minutes ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 03/09/2026 at 17:45, 1 hour 31 minutes ago

    Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026

  • Published on 03/09/2026 at 17:35, 1 hour 41 minutes ago

    Disclosure of transactions in own shares from March 2 to March 6, 2026

  • Published on 03/09/2026 at 08:45, 10 hours 31 minutes ago

    Share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy